TOKYO, July 7, 2025 /PRNewswire/ — Simplex Quantum, an AI-driven healthcare technology company, is proud to announce that Dr. Marco Perez, Associate Professor of Medicine at Stanford University and a renowned expert in cardiac electrophysiology, has agreed to act as an advisor to Simplex Quantum.
Dr. Perez brings extensive experience in heart rhythm disorders, predictive cardiology, and AI applications in cardiovascular health. He was a principal investigator in the landmark Apple Heart Study, one of the largest digital health studies to date, which explored the use of wearable technology to detect atrial fibrillation. His expertise in leveraging AI and big data to improve heart health will be instrumental in guiding Simplex Quantum’s flagship technology, NIHA-HF, an AI-powered software designed to assist in early heart failure detection and management.
“We are honored to have Dr. Perez join us as an advisor,” said Ryu Saito, CEO of Simplex Quantum. “His pioneering work in AI-driven cardiology, particularly with large-scale digital health studies like the Apple Heart Study, aligns perfectly with our vision. With his guidance, we aim to further our mission of making heart failure detection more accurate, accessible, and proactive.”
Simplex Quantum is at the forefront of leveraging artificial intelligence to improve cardiovascular health. NIHA-HF analyzes ECG data to help healthcare providers detect early signs of heart failure, enabling timely intervention and better patient outcomes. Dr. Perez’s involvement will accelerate the clinical validation and integration of the technology into broader healthcare ecosystems.
“AI has the potential to transform how we diagnose and manage heart disease,” said Dr. Marco Perez. “Simplex Quantum is taking significant steps towards the implementation of AI tools to detect heart failure into the clinic. I look forward to working with Simplex Quantum to help advance this important innovation.”
With this strategic advisory appointment, Simplex Quantum reaffirms its commitment to bridging the gap between cutting-edge AI and real-world clinical applications, driving meaningful advancements in cardiovascular care.
About Simplex Quantum
Simplex Quantum is a Tokyo-based AI healthcare company focused on transforming cardiovascular diagnostics. Its flagship product, NIHA-HF, leverages AI to enhance early detection and management of heart failure, improving patient care and clinical decision-making.
Learn more: https://simplex-q.com/
Note: NIHA-HF is an investigational device and has not been approved by the FDA.
For media inquiries, please contact:
Moe Kawai
+81 3-6450-3600
[email protected]
SOURCE Simplex Quantum
